RHUMBLINE ADVISERS - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$22,000
-87.7%
34,480
-39.2%
0.00%
Q3 2016$179,000
+2.9%
56,699
+0.5%
0.00%
-100.0%
Q2 2016$174,000
+26.1%
56,389
+47.4%
0.00%
Q1 2016$138,000
-22.0%
38,254
+0.3%
0.00%
-100.0%
Q4 2015$177,000
-15.7%
38,154
+10.6%
0.00%0.0%
Q3 2015$210,000
-20.5%
34,499
+12.5%
0.00%0.0%
Q2 2015$264,00030,6700.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders